Prevalence of anxiety and depression risk during the prepartum period in the different groups of women and responses from the Italian National Health Service.


Journal

Minerva pediatrics
ISSN: 2724-5780
Titre abrégé: Minerva Pediatr (Torino)
Pays: Italy
ID NLM: 101777303

Informations de publication

Date de publication:
31 Oct 2023
Historique:
medline: 31 10 2023
pubmed: 31 10 2023
entrez: 31 10 2023
Statut: aheadofprint

Résumé

Specific screening for anxiety and depression in pregnant women is important to identify those at risk and to provide timely intervention. The aims of the study were: 1) to compare the risk of anxiety and depression in four groups of pregnant women belonging to four types of healthcare centers distinguished by the level of risk: at low-risk; at high-risk for an obstetric reason; at high-risk for fetal anomalies; at high-risk for psychiatric conditions and 2) to identify the response that the National Health Service offers to women positively screened for anxiety and depression. A cross-sectional study was conducted on 2801 pregnant women, cared for by National Health Service, divided into four groups: 1) low-risk pregnancy (N.=1970); 2) high-risk pregnancy for an obstetric reason (N.=218); 3) high-risk for fetal anomalies (N.=505); and 4) high-risk for psychiatric conditions (N.=108). Participants were screened using the Edinburgh Postnatal Depression Scale, the General Anxiety Disorder, and sociodemographic, anamnestic, and clinic questionnaires. 28.9% of participants obtained an EPDS Score ≥9 and 17.1% a GAD-7 Score ≥8. The group at high-risk for fetal anomalies presented the highest prevalence of anxiety (29.3%) and depression (49.1%) while the group at low risk presented the lowest prevalence of anxiety (13%) and depression (24.6%). The groups at risk for obstetric reasons presented an intermediate prevalence. Psychiatric conditions constituted a higher risk for anxiety than depression. Counselling is recommended for about 70% of women at risk for anxiety and depression. Moreover, about 15% of women positive for screening were initiated into psychotherapy and about 1.5% into pharmacotherapy. 15% of women positive for screening were referred to other specialists. This study underlined the relevance of a prompt response by the National Health Service to mental health needs, especially in the risk conditions related to obstetric and/or fetal anomalies and psychopathology.

Sections du résumé

BACKGROUND BACKGROUND
Specific screening for anxiety and depression in pregnant women is important to identify those at risk and to provide timely intervention. The aims of the study were: 1) to compare the risk of anxiety and depression in four groups of pregnant women belonging to four types of healthcare centers distinguished by the level of risk: at low-risk; at high-risk for an obstetric reason; at high-risk for fetal anomalies; at high-risk for psychiatric conditions and 2) to identify the response that the National Health Service offers to women positively screened for anxiety and depression.
METHODS METHODS
A cross-sectional study was conducted on 2801 pregnant women, cared for by National Health Service, divided into four groups: 1) low-risk pregnancy (N.=1970); 2) high-risk pregnancy for an obstetric reason (N.=218); 3) high-risk for fetal anomalies (N.=505); and 4) high-risk for psychiatric conditions (N.=108). Participants were screened using the Edinburgh Postnatal Depression Scale, the General Anxiety Disorder, and sociodemographic, anamnestic, and clinic questionnaires.
RESULTS RESULTS
28.9% of participants obtained an EPDS Score ≥9 and 17.1% a GAD-7 Score ≥8. The group at high-risk for fetal anomalies presented the highest prevalence of anxiety (29.3%) and depression (49.1%) while the group at low risk presented the lowest prevalence of anxiety (13%) and depression (24.6%). The groups at risk for obstetric reasons presented an intermediate prevalence. Psychiatric conditions constituted a higher risk for anxiety than depression. Counselling is recommended for about 70% of women at risk for anxiety and depression. Moreover, about 15% of women positive for screening were initiated into psychotherapy and about 1.5% into pharmacotherapy. 15% of women positive for screening were referred to other specialists.
CONCLUSIONS CONCLUSIONS
This study underlined the relevance of a prompt response by the National Health Service to mental health needs, especially in the risk conditions related to obstetric and/or fetal anomalies and psychopathology.

Identifiants

pubmed: 37906132
pii: S2724-5276.23.07410-4
doi: 10.23736/S2724-5276.23.07410-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Martina Smorti (M)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, Hospital of Pisa, University of Pisa, Pisa, Italy.

Fiorino Mirabella (F)

Center for Behavioral Sciences and Mental Health, Italian National Health Institute, Rome, Italy.

Gemma Calamandrei (G)

Center for Behavioral Sciences and Mental Health, Italian National Health Institute, Rome, Italy.

Antonella Gigantesco (A)

Center for Behavioral Sciences and Mental Health, Italian National Health Institute, Rome, Italy.

Giulia Mauri (G)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, Hospital of Pisa, University of Pisa, Pisa, Italy.

Sonia Brescianini (S)

Center for Behavioral Sciences and Mental Health, Italian National Health Institute, Rome, Italy.

Franca Aceti (F)

Service of Perinatal Psychopathology, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy.

Ilaria Adulti (I)

Perinatal Depression Multicentric Observatory, Tor Vergata University, Rome, Italy.

Pietro Bagolan (P)

Unit of Clinical Psychology, Department of Fetal and Perinatal Medicine and Surgery, Bambino Gesù Children's Hospital, Rome, Italy.

Gina Barbano (G)

AULSS 2/Marca Trevigiana - Distretto Treviso Nord, Oderzo, Treviso, Italy.

Antonello Bellomo (A)

Perinatal Depression Multicentric Observatory, Maternal-Child Health Centers, Foggia, Italy.

Marina Cattaneo (M)

Local Health Authority Bergamo Ovest, Maternal-Child Health Centers, Bergamo, Italy.

Elda Cengia (E)

Unit of Obstetrics and Gynecology, AULSS 1 Dolomiti, Hospital of Feltre, Feltre, Belluno, Italy.

Angela Fabiano (A)

Local Health Authority, Maternal-Child Health Centers, Catania, Italy.

Alice Fent (A)

Unit of Obstetrics and Gynecology, AULSS 1 Dolomiti, Hospital of Feltre, Feltre, Belluno, Italy.

Laura Ferraro (L)

Perinatal Depression Multicentric Observatory, Maternal-Child Health Centers, Palermo, Italy.

Nicoletta Giacchetti (N)

Service of Perinatal Psychopathology, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy.

Teresa Grimaldi Capitello (T)

Unit of Clinical Psychology, Department of Fetal and Perinatal Medicine and Surgery, Bambino Gesù Children's Hospital, Rome, Italy.

Antonella Grillo (A)

Local Health Authority, Maternal-Child Health Centers, Catania, Italy.

Daniele LA Barbera (D)

Perinatal Depression Multicentric Observatory, Maternal-Child Health Centers, Palermo, Italy.

Angelo Marcheggiani (A)

Local Health Authority, Maternal-Child Health Centers, Campobasso, Italy.

Marianna Mazza (M)

Perinatal Depression Multicentric Observatory, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.

Loredana Messina (L)

Unit of Obstetrics and Gynecology, Buccheri La Ferla Hospital, Palermo, Italy.

Cinzia Niolu (C)

Perinatal Depression Multicentric Observatory, Tor Vergata University, Rome, Italy.

Giovanna Picciano (G)

Local Health Authority, Maternal-Child Health Centers, Campobasso, Italy.

Maria Pistillo (M)

ASP Enna, Enna, Italy.

Myriam Regonesi (M)

Local Health Authority Bergamo Ovest, Maternal-Child Health Centers, Bergamo, Italy.

Rossana Riolo (R)

Maternal and Paternal Perinatal Disorder Service, Department of Local Psychiatry, AULSS 8 Berica, Vicenza, Italy.

Gabriele Sani (G)

Perinatal Depression Multicentric Observatory, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.

Antonella Triggiani (A)

Unit of Obstetrics and Gynecology, Cristo Re Hospital, Rome, Italy.

Damiana Tomasello (D)

Local Health Authority, Maternal-Child Health Centers, Catania, Italy.

Laura Camoni (L)

Center for Behavioral Sciences and Mental Health, Italian National Health Institute, Rome, Italy - laura.camoni@iss.it.

Classifications MeSH